<html><body><h2>Case: 1943308</h2><h3> CDS Time: 1987-09-15</h3>
<patient name=1943308>
87.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">87</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">9</td><td width="200">1987-3-4</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">86</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">100</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">Chloride</td><td width="200">103.0</td><td width="200">1987-3-4</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">44</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">61</td><td width="200">1987-9-15</td></tr>
<tr><td width="200">B 12</td><td width="200">217</td><td width="200">1984-7-13</td></tr>
<tr><td width="200">Weight</td><td width="200">140</td><td width="200">1987-9-15</td></tr>
<tr><td width="200">HbA1C</td><td width="200">11</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">236</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">Urine_ALB/CREAT_RATIO_spot</td><td width="200">25</td><td width="200">1985-1-12</td></tr>
<tr><td width="200">Urine_Alb/creat_Ratio_24h</td><td width="200">25</td><td width="200">1985-1-12</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">173</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">SGOT</td><td width="200">51</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">149</td><td width="200">1987-9-15</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">Height</td><td width="200">65</td><td width="200">1987-7-25</td></tr>
<tr><td width="200">Potassium</td><td width="200">5</td><td width="200">1987-3-4</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">173</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">BUN</td><td width="200">29</td><td width="200">1987-3-4</td></tr>
<tr><td width="200">HCT</td><td width="200">44</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">HGB</td><td width="200">15</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">Sodium</td><td width="200">136</td><td width="200">1987-3-4</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.8</td><td width="200">1987-3-4</td></tr>
<tr><td width="200">UrineAlbumin_24H</td><td width="200">28</td><td width="200">1985-1-12</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">11</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">UrineAlbumin_SPOT</td><td width="200">28</td><td width="200">1985-1-12</td></tr>
<tr><td width="200">Pulse</td><td width="200">80</td><td width="200">1987-9-15</td></tr>
<tr><td width="200">PLT</td><td width="200">221</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">WBC</td><td width="200">9</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">eGFR</td><td width="200">28</td><td width="200">1987-3-4</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1987-5-3</td></tr>
<tr><td width="200">SGPT</td><td width="200">41</td><td width="200">1987-1-18</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1987-8-22</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1987-8-22</td></tr>
<tr><td width="200">PVD</td><td width="200"></td><td width="200">1987-2-15</td></tr>
<tr><td width="200">Sinoatrial node dysfunction</td><td width="200"></td><td width="200">1987-8-22</td></tr>
<tr><td width="200">Liver_Disease</td><td width="200"></td><td width="200">1987-8-5</td></tr>
<tr><td width="200">Pacemaker</td><td width="200"></td><td width="200">1987-8-22</td></tr>
<tr><td width="200">Myocardial_Infarction</td><td width="200"></td><td width="200">1987-8-22</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1987-2-15</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1987-5-3</td></tr>
</table>
<p><b>Medications:</b> glyburide(10.0) aspirin(325.0) metformin(0.0) amiodarone(200.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Sinoatrial node dysfunction</td>
<td width="200">1987-08-22</td>
<td width="200"> Sinoatrial node dysfunction()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200">1987-08-05</td>
<td width="200"> Liver_Disease()</td></tr>
<tr><td width="200">CCS-7.4</td>
<td width="200">1987-02-15</td>
<td width="200"> PVD()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1987-08-22</td>
<td width="200"> Myocardial_Infarction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1987-08-22</td>
<td width="200"> Sinoatrial node dysfunction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1987-08-22</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1987-02-15</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Pacemaker</td>
<td width="200">1987-08-22</td>
<td width="200"> Pacemaker()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1987-08-22</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1987-05-03</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200">Creatinine > 1.4 and Female</td>
<td width="200"></td>
<td width="200"> Creatinine > 1.4 and Female[Sex(Female) && Creatinine(1.8/1987-3-4)]()</td></tr>
<tr><td width="200">Age>80 yrs</td>
<td width="200"></td>
<td width="200"> Age>80yrs[Age(87.0/1970-1-1)]()</td></tr>
<tr><td width="200">eGFR < 30</td>
<td width="200"></td>
<td width="200"> eGFR <30[eGFR(28.0/1987-3-4)]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA DM: Glycemic Control</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA DM: Glycemic Control: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(diabetes_mellitus)</i>]
</ul>
<b>Scenario choice:</b> Nonpharmacologic Therapy
<p>
<b>Goal:</b> HBA1C <= target(presence of target HBA1C)
<p><b>Reached goal?</b> failed(HbA1C(11.1/1987-1-18))
<p><b>Messages by Types</b>
<ul>
<li><b>Primary_Recommendation</b>
<ul>
<li>Consider aspirin therapy to reduce the risk of cardiovascular fatal events.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Nonpharmacologic therapy</b><br>
<ul>
<li><b>Start aspirin <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Consider aspirin therapy to reduce the risk of cardiovascular fatal events.
</ul>
<li><b>DM - No meds</b><br>
<ul>
<li><b>Is patient high risk? If yes, refer <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])


<li><b>Metformin contraindicated, add Glipizide <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HbA1C > Target_HbA1c</i> evaluate to <b> true</b> because <i>HbA1C(11.1/1987-1-18)</i>)])
Add Glipizide
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>GLIPIZIDE(GLIPIZIDE)<ul><li>Relative indications:  DM-Type2(DM-Type2) <li>Sulfonylurea general info when prescribing(•	Efficacy ( HbA1c) a = 1.0 - 2.0 %
•	1st generation sulfonylureas are no longer commonly used.
•	No difference in long term efficacy or failure rate has been demonstrated among the sulfonylureas.
•	The preferred agents have shorter half-lives and inactive metabolites.
•	1st generation sulfonylureas are 100% renally eliminated. Chlorpropamide and tolazamide have active metabolites.
•	Glipizide, glyburide, and glimepiride are renally eliminated by 80 - 85%, 50%, and 60% respectively. All but glipizide have active metabolites.
•	Inexpensive)<li>preference: preferred</ul></ul></body></html>